Price (delayed)
$1.35
Market cap
$17.46M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$7.9
Enterprise value
$12.63M
Athersys is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing
There are no recent dividends present for ATHX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.